Latest news with #YoshiyukiAikawa
Yahoo
21-07-2025
- Business
- Yahoo
SBC Medical Group收購MB Career Lounge：「JUN CLINIC」加入集團，強化其在成長型市場中的競爭地位
JUN CLINIC 加州爾灣, July 18, 2025--(BUSINESS WIRE)--(美國商業資訊)--全球美妝診所特許經營商及服務提供者SBC Medical Group Holdings Incorporated (Nasdaq: SBC)（簡稱「SBC Medical」或「公司」）宣布，於2025年7月17日透過現金收購股權的方式完成了對MB career lounge, Co., Ltd. ("MB career lounge")的收購，後者是一家私人企業，專注於為日本醫療機構提供管理支援服務，業務涵蓋顧問、培訓及人力資源解決方案。 廣告 廣告 透過此次交易，由醫療法人Misakikai營運、並獲得MB career lounge支援的JUN CLINIC將加入SBC Medical的診所網路，這有助於豐富公司的業務組合，並可望增強收入穩定性。 SBC Medical創辦人兼執行長Yoshiyuki Aikawa表示：「個人化美妝解決方案的需求激增，尤其是『客製化雷射治療』，彰顯了這一市場的快速擴張。JUN CLINIC在不同環境中均取得了公認的成功——從長野這樣的發展中地區市場，到競爭激烈的銀座、白金台等市中心區域，這充分證明了其業務模式的穩健性和易擴充性，為全國性擴張奠定了基礎。透過整合我們與MB career lounge及JUN CLINIC的優勢，我們將強化美妝皮膚科和整形外科服務組合，提升為客戶提供更高效服務的能力，並進一步協助公司把握高品質美妝醫療服務與日俱增的需求所帶來的商機。此次收購是我們成長策略中的又一重要措施，將加快區域擴張、豐富服務品類，並強化我們為股東創造長期價值的承諾。我們期待歡迎MB career lounge和JUN CLINIC團隊的加入，攜手共創持續成功。」 廣告 廣告 2024年，日本美妝醫療市場規模達到6310億日圓，較去年同期成長6.2%，且可望繼續穩步擴張。*在此背景下，SBC Medical欣然歡迎成熟的美妝皮膚科及整形外科服務提供者JUN CLINIC加入其不斷擴大的診所網路。 JUN CLINIC的診所據點遍布多地，包括白金台、銀座、多摩廣場、橫濱及長野，為都市和地區的各類客戶群體提供服務。該診所以個人化治療方案著稱，提供雷射治療、注射美妝、線雕拉提等全方位服務，所有服務均根據個人皮膚狀況量身打造，並在經董事會認證的皮膚科醫生的監督下進行。 廣告 廣告 此次收購使SBC Medical能夠加快區域擴張、擴大客戶群體，並透過減少對單一診療專案或地區的依賴來強化業務模式。憑藉JUN CLINIC的長期聲譽和穩定收入基礎，此次收購可望提升SBC Medical的財務表現。展望未來，SBC Medical將繼續尋求對高品質醫療機構的策略收購與合作，以支援長期成長，並在醫療健康產業創造更大的企業價值。 這一頂級治療平台的加入與SBC Medical豐富服務品類、擴大業務組合的策略相契合，順應了個人化醫療的重要趨勢。全球對客製化非侵入性美妝解決方案的需求可望實現顯著且持久的成長。SBC Medical致力於把握這一高價值區隔市場的商機，包括透過整合JUN CLINIC經實務驗證的模式及其高素質專業團隊——該團隊身為著名Customized Treatment Study Group認證機構的專業資質即是其專業性的明證。 廣告 廣告 （*來源：Yano Research Institute Ltd.，《2025年日本美妝醫療市場調查報告》） 關於MB career lounge, Co., Ltd. MB career lounge, Co., Ltd.是一家專注於美妝醫療產業的顧問公司。MB career lounge提供廣泛的培訓和人脈擴展計畫，旨在提升醫生、護士及診所管理者的知識、技能和職業發展水準。除教育計畫外，MB career lounge還提供全方位的顧問服務，包括診所開幕支援、行銷策略、營運最佳化、管理結構建設以及美妝醫療器材的選型與應用等。此外，MB career lounge還為醫療法人Misakikai營運的JUN CLINIC提供管理支援。MB career lounge的使命是協助診所解決管理難題、實現永續成長，並打造病患信賴的醫療機構。 交易概況 交易類型：現金收購股權 完成日期：2025年7月17日 合併日期：2025年第三季 資金來源：銀行貸款 關於SBC Medical SBC Medical總部位於加州爾灣和日本東京，擁有並為美妝治療中心提供管理服務和產品。公司主要專注於為加盟診所提供全面的管理服務，包括但不限於跨各種平台（如社群媒體網路）的廣告和行銷需求、員工管理（如招募和培訓）、加盟診所客戶預訂、協助加盟診所員工進行房屋和設施租賃、加盟診所的建設和設計、醫療器材和醫療消耗品採購（轉售）、向加盟診所提供化妝品以向診所客戶轉售、正在申請專利和非專利醫療技術的使用授權、商標和品牌使用、IT軟體解決方案（包括但不限於遠端醫療顧問）、管理加盟診所的客戶獎勵計畫（客戶忠誠度積分計畫），以及針對加盟診所的支付工具。如欲瞭解更多資訊，請造訪 前瞻性陳述 本新聞稿包含前瞻性陳述。前瞻性陳述並非歷史事實或目前狀況的陳述，而是僅代表公司對未來事件和業績的信念，其中許多就其性質而言具有內在的不確定性，並且不在公司掌控範圍內。這些前瞻性陳述反映了公司目前對其收購MB career lounge；產品發表計畫和策略；收入和收益的成長；以及商業前景等的看法。在某些情況下，前瞻性陳述可以透過諸如「可能」、「應該」、「期望」、「預期」、「考量」、「估計」、「相信」、「計畫」、「預計」、「預測」、「潛在」、「目標」或「希望」等字詞或者這些或類似字詞的否定形式的使用來加以辨識。公司提醒讀者不要過分依賴任何前瞻性陳述，這些陳述僅反映本新聞稿發表之日的情況，並受到難以預測或量化的各種風險、不確定性、假設或情況變化的影響。前瞻性陳述依據管理層的目前預期，並非對未來業績的保證。除非法律要求，否則公司不承擔或接受任何公開發表對任何前瞻性陳述的任何更新或修訂的義務，以反映其預期的任何變化，或者任何此類陳述所依據的事件、條件或情況的任何變化。可能導致實際結果與目前預期大相逕庭的因素可能不時出現，公司無法預測所有這些因素；此類因素包括全球、區域或當地經濟、商業、競爭、市場和監管條件的變化，以及公司向美國證券交易委員會(SEC)遞交的文件的「風險因素」標題下和其他部分列出的因素，這些文件可在SEC網站上查閱，網址為 廣告 廣告 免責聲明：本公告之原文版本乃官方授權版本。譯文僅供方便瞭解之用，煩請參照原文，原文版本乃唯一具法律效力之版本。 請前往 瀏覽源版本: Contacts SBC Medical Group Holdings Incorporated（亞洲） Hikaru Fukui / 投資人關係負責人 電子郵件：ir@ Akiko Wakiyama/ 公共關係負責人 電子郵件：pr@ ICR LLC（美國） Bill Zima / 管理合夥人 電子郵件：
Business Upturn
17-07-2025
- Business
- Business Upturn
SBC Medical Group Acquires MB Career Lounge: 'JUN CLINIC' Joins the Group, Strengthening Competitive Position in a Growing Market
By Business Wire India Published on July 17, 2025, 17:22 IST Business Wire India SBC Medical Group Holdings Incorporated (Nasdaq: SBC) ('SBC Medical' or the 'Company'), a global franchise and provider of services for aesthetic clinics, announced that, on July 17, 2025, it acquired MB career lounge, Co., Ltd. ('MB career lounge'), a privately-held provider of management support services for medical institutions, specializing in consulting, training, and human resources solutions in Japan, through a share purchase transaction for cash consideration. This press release features multimedia. View the full release here: JUN CLINIC Through this transaction, JUN CLINIC, operated by Medical Corporation Misakikai and supported by MB career lounge, will join SBC Medical's clinic network, contributing to portfolio diversification and is expected to enhance revenue stability. 'The surging demand for personalized aesthetic solutions, particularly 'Customized Laser Treatment,' underscores a rapidly expanding market. JUN CLINIC's proven success in diverse environments, from the developing regional market of Nagano to the highly competitive urban centers of Ginza and Shirokane, demonstrates a robust and easily scalable business model poised for nationwide expansion. By combining our strengths with MB career lounge and JUN CLINIC, we will strengthen our portfolio of aesthetic dermatology and plastic surgery services, enhancing our ability to serve our customers more effectively and further positioning the Company to capitalize on the growing demand for high-quality aesthetic medical services,' said Yoshiyuki Aikawa, Founder and Chief Executive Officer of SBC Medical. 'This acquisition marks another important step in our growth strategy, accelerating regional expansion, diversifying service offerings, and reinforcing our commitment to driving long-term shareholder value. We look forward to welcoming the MB career lounge and JUN CLINIC team and working together to drive continued success.' Japan's aesthetic medicine market reached ¥631 billion in 2024, representing year-over-year growth of 6.2%, and is expected to continue its steady expansion.* Against this backdrop, SBC Medical is pleased to welcome JUN CLINIC—an established provider of both aesthetic dermatology and plastic surgery services—into its growing clinic network. JUN CLINIC is a network of clinics across multiple locations, including Shirokane, Ginza, Tama Plaza, Yokohama, and Nagano, serving a diverse customer base across both metropolitan and regional areas. Renowned for its personalized treatment approach, the clinic offers a comprehensive suite of services including laser therapies, injectables, and thread lifts, all tailored to individual skin conditions and administered under the supervision of a board-certified dermatologist. This acquisition enables SBC Medical to accelerate regional expansion, broaden its customer base and strengthen its business model by reducing reliance on any single procedure or geography. With JUN CLINIC's long-standing reputation and stable revenue base, the acquisition is expected to enhance SBC Medical's financial performance. Looking ahead, SBC Medical will continue to pursue strategic acquisitions and partnerships with high-quality medical institutions to support long-term growth and drive greater corporate value within the healthcare industry. The addition of this sophisticated treatment platform aligns with SBC Medical's strategy of diversifying its service offerings and expanding its portfolio to embrace the significant trend of personalized medicine. The global demand for customized, non-invasive aesthetic solutions has the potential to achieve meaningful and durable growth. SBC Medical endeavors to capture this high-value market segment, including through integration of JUN CLINIC's proven model and its team of highly skilled professionals—validated by their role as a certified facility for the prestigious Customized Treatment Study Group. (*Source: Yano Research Institute Ltd., 'Survey on Japan's Aesthetic Medicine Market 2025') About MB career lounge, Co., Ltd. MB career lounge, Co., Ltd. is a consulting firm specializing in the aesthetic medical industry. MB career lounge offers a wide range of training and networking programs designed to enhance the knowledge, skills, and career development of doctors, nurses, and clinic managers. In addition to educational initiatives, MB career lounge provides comprehensive consulting services, including support for clinic startups, marketing strategies, operational optimization, management structure development, and selection and implementation of aesthetic medical devices. MB career lounge also provides management support for JUN CLINIC, operated by the medical corporation Misakikai. MB career lounge's mission is to help clinics solve management challenges, achieve sustainable growth, and build trusted practices that patients choose. (Japanese only) Transaction Overview Transaction Type: Share acquisition with cash consideration Closing Date: July 17, 2025 Consolidation Date: Q3 2025 Funding Source: Bank loan About SBC Medical SBC Medical, headquartered in Irvine, California and Tokyo, Japan, owns and provides management services and products to cosmetic treatment centers. The Company is primarily focused on providing comprehensive management services to franchisee clinics, including but not limited to advertising and marketing needs across various platforms (such as social media networks), staff management (such as recruitment and training), booking reservations for franchisee clinic customers, assistance with franchisee employee housing rentals and facility rentals, construction and design of franchisee clinics, medical equipment and medical consumables procurement (resale), the provision of cosmetic products to franchisee clinics for resale to clinic customers, licensure of the use of patent-pending and non-patented medical technologies, trademark and brand use, IT software solutions (including but not limited to remote medical consultations), management of the franchisee clinic's customer rewards program (customer loyalty point program), and payment tools for the franchisee clinics. For more information, visit Forward-Looking Statements This press release contains forward-looking statements. Forward-looking statements are not historical facts or statements of current conditions, but instead represent only the Company's beliefs regarding future events and performance, many of which, by their nature, are inherently uncertain and outside of the Company's control. These forward-looking statements reflect the Company's current views with respect to, among other things, the Company's acquisition of MB career lounge, product launch plans and strategies; growth in revenue and earnings; and business prospects. In some cases, forward-looking statements can be identified by the use of words such as 'may,' 'should,' 'expects,' 'anticipates,' 'contemplates,' 'estimates,' 'believes,' 'plans,' 'projected,' 'predicts,' 'potential,' 'targets' or 'hopes' or the negative of these or similar terms. The Company cautions readers not to place undue reliance upon any forward-looking statements, which are current only as of the date of this release and are subject to various risks, uncertainties, assumptions, or changes in circumstances that are difficult to predict or quantify. The forward-looking statements are based on management's current expectations and are not guarantees of future performance. The Company does not undertake or accept any obligation to release publicly any updates or revisions to any forward-looking statements to reflect any change in its expectations or any change in events, conditions, or circumstances on which any such statement is based, except as required by law. Factors that may cause actual results to differ materially from current expectations may emerge from time to time, and it is not possible for the Company to predict all of them; such factors include, among other things, changes in global, regional, or local economic, business, competitive, market and regulatory conditions, and those listed under the heading 'Risk Factors' and elsewhere in the Company's filings with the U.S. Securities and Exchange Commission (the 'SEC'), which are accessible on the SEC's website at View source version on Disclaimer: The above press release comes to you under an arrangement with Business Wire India. Business Upturn take no editorial responsibility for the same. Ahmedabad Plane Crash Business Wire India, established in 2002, India's premier media distribution company ensures guaranteed media coverage through its network of 30+ cities and top news agencies.
Business Wire
17-07-2025
- Business
- Business Wire
SBC Medical Group Acquires MB Career Lounge: 'JUN CLINIC' Joins the Group, Strengthening Competitive Position in a Growing Market
IRVINE, Calif.--(BUSINESS WIRE)--SBC Medical Group Holdings Incorporated (Nasdaq: SBC) ('SBC Medical' or the 'Company'), a global franchise and provider of services for aesthetic clinics, announced that, on July 17, 2025, it acquired MB career lounge, Co., Ltd. ('MB career lounge'), a privately-held provider of management support services for medical institutions, specializing in consulting, training, and human resources solutions in Japan, through a share purchase transaction for cash consideration. Through this transaction, JUN CLINIC, operated by Medical Corporation Misakikai and supported by MB career lounge, will join SBC Medical's clinic network, contributing to portfolio diversification and is expected to enhance revenue stability. 'The surging demand for personalized aesthetic solutions, particularly 'Customized Laser Treatment,' underscores a rapidly expanding market. JUN CLINIC's proven success in diverse environments, from the developing regional market of Nagano to the highly competitive urban centers of Ginza and Shirokane, demonstrates a robust and easily scalable business model poised for nationwide expansion. By combining our strengths with MB career lounge and JUN CLINIC, we will strengthen our portfolio of aesthetic dermatology and plastic surgery services, enhancing our ability to serve our customers more effectively and further positioning the Company to capitalize on the growing demand for high-quality aesthetic medical services,' said Yoshiyuki Aikawa, Founder and Chief Executive Officer of SBC Medical. 'This acquisition marks another important step in our growth strategy, accelerating regional expansion, diversifying service offerings, and reinforcing our commitment to driving long-term shareholder value. We look forward to welcoming the MB career lounge and JUN CLINIC team and working together to drive continued success.' Japan's aesthetic medicine market reached ¥631 billion in 2024, representing year-over-year growth of 6.2%, and is expected to continue its steady expansion.* Against this backdrop, SBC Medical is pleased to welcome JUN CLINIC—an established provider of both aesthetic dermatology and plastic surgery services—into its growing clinic network. JUN CLINIC is a network of clinics across multiple locations, including Shirokane, Ginza, Tama Plaza, Yokohama, and Nagano, serving a diverse customer base across both metropolitan and regional areas. Renowned for its personalized treatment approach, the clinic offers a comprehensive suite of services including laser therapies, injectables, and thread lifts, all tailored to individual skin conditions and administered under the supervision of a board-certified dermatologist. This acquisition enables SBC Medical to accelerate regional expansion, broaden its customer base and strengthen its business model by reducing reliance on any single procedure or geography. With JUN CLINIC's long-standing reputation and stable revenue base, the acquisition is expected to enhance SBC Medical's financial performance. Looking ahead, SBC Medical will continue to pursue strategic acquisitions and partnerships with high-quality medical institutions to support long-term growth and drive greater corporate value within the healthcare industry. The addition of this sophisticated treatment platform aligns with SBC Medical's strategy of diversifying its service offerings and expanding its portfolio to embrace the significant trend of personalized medicine. The global demand for customized, non-invasive aesthetic solutions has the potential to achieve meaningful and durable growth. SBC Medical endeavors to capture this high-value market segment, including through integration of JUN CLINIC's proven model and its team of highly skilled professionals—validated by their role as a certified facility for the prestigious Customized Treatment Study Group. (*Source: Yano Research Institute Ltd., 'Survey on Japan's Aesthetic Medicine Market 2025') About MB career lounge, Co., Ltd. MB career lounge, Co., Ltd. is a consulting firm specializing in the aesthetic medical industry. MB career lounge offers a wide range of training and networking programs designed to enhance the knowledge, skills, and career development of doctors, nurses, and clinic managers. In addition to educational initiatives, MB career lounge provides comprehensive consulting services, including support for clinic startups, marketing strategies, operational optimization, management structure development, and selection and implementation of aesthetic medical devices. MB career lounge also provides management support for JUN CLINIC, operated by the medical corporation Misakikai. MB career lounge's mission is to help clinics solve management challenges, achieve sustainable growth, and build trusted practices that patients choose. (Japanese only) Transaction Overview Transaction Type: Share acquisition with cash consideration Closing Date: July 17, 2025 Consolidation Date: Q3 2025 Funding Source: Bank loan About SBC Medical SBC Medical, headquartered in Irvine, California and Tokyo, Japan, owns and provides management services and products to cosmetic treatment centers. The Company is primarily focused on providing comprehensive management services to franchisee clinics, including but not limited to advertising and marketing needs across various platforms (such as social media networks), staff management (such as recruitment and training), booking reservations for franchisee clinic customers, assistance with franchisee employee housing rentals and facility rentals, construction and design of franchisee clinics, medical equipment and medical consumables procurement (resale), the provision of cosmetic products to franchisee clinics for resale to clinic customers, licensure of the use of patent-pending and non-patented medical technologies, trademark and brand use, IT software solutions (including but not limited to remote medical consultations), management of the franchisee clinic's customer rewards program (customer loyalty point program), and payment tools for the franchisee clinics. For more information, visit Forward-Looking Statements This press release contains forward-looking statements. Forward-looking statements are not historical facts or statements of current conditions, but instead represent only the Company's beliefs regarding future events and performance, many of which, by their nature, are inherently uncertain and outside of the Company's control. These forward-looking statements reflect the Company's current views with respect to, among other things, the Company's acquisition of MB career lounge, product launch plans and strategies; growth in revenue and earnings; and business prospects. In some cases, forward-looking statements can be identified by the use of words such as 'may,' 'should,' 'expects,' 'anticipates,' 'contemplates,' 'estimates,' 'believes,' 'plans,' 'projected,' 'predicts,' 'potential,' 'targets' or 'hopes' or the negative of these or similar terms. The Company cautions readers not to place undue reliance upon any forward-looking statements, which are current only as of the date of this release and are subject to various risks, uncertainties, assumptions, or changes in circumstances that are difficult to predict or quantify. The forward-looking statements are based on management's current expectations and are not guarantees of future performance. The Company does not undertake or accept any obligation to release publicly any updates or revisions to any forward-looking statements to reflect any change in its expectations or any change in events, conditions, or circumstances on which any such statement is based, except as required by law. Factors that may cause actual results to differ materially from current expectations may emerge from time to time, and it is not possible for the Company to predict all of them; such factors include, among other things, changes in global, regional, or local economic, business, competitive, market and regulatory conditions, and those listed under the heading 'Risk Factors' and elsewhere in the Company's filings with the U.S. Securities and Exchange Commission (the 'SEC'), which are accessible on the SEC's website at
Associated Press
28-06-2025
- Business
- Associated Press
SBC Medical added to membership of Russell 3000® Index
IRVINE, Calif.--(BUSINESS WIRE)--Jun 27, 2025-- SBC Medical Group Holdings Incorporated (Nasdaq: SBC) ('SBC Medical'), a global franchise and provider of services for aesthetic clinics, has been added as a member of the broad-market Russell 3000 ® Index, effective after the US market opens on June 30, as part of the 2025 Russell indexes reconstitution. This press release features multimedia. View the full release here: Yoshiyuki Aikawa-Director (Chairman), CEO Membership in the Russell 3000 ® Index, which remains in place for one year, means automatic inclusion in the large-cap Russell 1000 ® Index or small-cap Russell 2000 ® Index as well as the appropriate growth and value style indexes. Russell indexes are widely used by investment managers and institutional investors for index funds and as benchmarks for active investment strategies. According to the data as of the end of June 2024, about $10.6 trillion in assets are benchmarked against the Russell US indexes, which belong to FTSE Russell, the global index provider. For more information on the Russell 3000 ® Index and the Russell indexes reconstitution, go to the 'Russell Reconstitution' section on the FTSE Russell website. About SBC Medical SBC Medical, headquartered in Irvine, California and Tokyo, Japan, owns and provides management services and products to cosmetic treatment centers. The Company is primarily focused on providing comprehensive management services to franchisee clinics, including but not limited to advertising and marketing needs across various platforms (such as social media networks), staff management (such as recruitment and training), booking reservations for franchisee clinic customers, assistance with franchisee employee housing rentals and facility rentals, construction and design of franchisee clinics, medical equipment and medical consumables procurement (resale), the provision of cosmetic products to franchisee clinics for resale to clinic customers, licensure of the use of patent-pending and non-patented medical technologies, trademark and brand use, IT software solutions (including but not limited to remote medical consultations), management of the franchisee clinic's customer rewards program (customer loyalty point program), and payment tools for the franchisee clinics. For more information, visit About FTSE Russell, an LSEG Business FTSE Russell is a global index leader that provides innovative benchmarking, analytics and data solutions for investors worldwide. FTSE Russell calculates thousands of indexes that measure and benchmark markets and asset classes in more than 70 countries, covering 98% of the investable market globally. FTSE Russell index expertise and products are used extensively by institutional and retail investors globally. Approximately $18.1 trillion is benchmarked to FTSE Russell indexes. Leading asset owners, asset managers, ETF providers and investment banks choose FTSE Russell indexes to benchmark their investment performance and create ETFs, structured products and index-based derivatives. A core set of universal principles guides FTSE Russell index design and management: a transparent rules-based methodology is informed by independent committees of leading market participants. FTSE Russell is focused on applying the highest industry standards in index design and governance and embraces the IOSCO Principles. FTSE Russell is also focused on index innovation and customer partnerships as it seeks to enhance the breadth, depth and reach of its offering. FTSE Russell is wholly owned by London Stock Exchange Group. For more information, visit FTSE Russell. Forward-Looking Statements This press release contains forward-looking statements. Forward-looking statements are not historical facts or statements of current conditions, but instead represent only the Company's beliefs regarding future events and performance, many of which, by their nature, are inherently uncertain and outside of the Company's control. These forward-looking statements reflect the Company's current views with respect to, among other things, the Company's product launch plans and strategies; growth in revenue and earnings; and business prospects. In some cases, forward-looking statements can be identified by the use of words such as 'may,' 'should,' 'expects,' 'anticipates,' 'contemplates,' 'estimates,' 'believes,' 'plans,' 'projected,' 'predicts,' 'potential,' 'targets' or 'hopes' or the negative of these or similar terms. The Company cautions readers not to place undue reliance upon any forward-looking statements, which are current only as of the date of this release and are subject to various risks, uncertainties, assumptions, or changes in circumstances that are difficult to predict or quantify. The forward-looking statements are based on management's current expectations and are not guarantees of future performance. The Company does not undertake or accept any obligation to release publicly any updates or revisions to any forward-looking statements to reflect any change in its expectations or any change in events, conditions, or circumstances on which any such statement is based, except as required by law. Factors that may cause actual results to differ materially from current expectations may emerge from time to time, and it is not possible for the Company to predict all of them; such factors include, among other things, changes in global, regional, or local economic, business, competitive, market and regulatory conditions, and those listed under the heading 'Risk Factors' and elsewhere in the Company's filings with the U.S. Securities and Exchange Commission (the 'SEC'), which are accessible on the SEC's website at View source version on CONTACT: SBC Medical Group Holdings Incorporated (Asia) Hikaru Fukui / Head of Investor Relations E-mail:[email protected] LLC (In the US) Bill Zima / Managing Partner Email:[email protected] KEYWORD: SOUTHEAST ASIA SINGAPORE NORTH AMERICA ASIA PACIFIC JAPAN EUROPE UNITED STATES UNITED KINGDOM CALIFORNIA INDUSTRY KEYWORD: MEDICAL SUPPLIES TECHNOLOGY PROFESSIONAL SERVICES OTHER HEALTH HEALTH HEALTH TECHNOLOGY MEDICAL DEVICES COSMETICS RETAIL DATA ANALYTICS SOFTWARE SOURCE: SBC Medical Group Holdings Incorporated Copyright Business Wire 2025. PUB: 06/27/2025 07:30 PM/DISC: 06/27/2025 07:31 PM
Globe and Mail
18-06-2025
- Business
- Globe and Mail
Participation in 'The 113th Congress of Japan Society of Aesthetic Surgery,' May 2025
IRVINE, Calif., June 17, 2025 (GLOBE NEWSWIRE) -- SBC Medical Group Holdings Incorporated (Nasdaq: SBC) ('SBC Medical') today announced that a total of 22 representatives, including Yoshiyuki Aikawa, CEO of SBC Medical, and doctors from Shonan Beauty Clinic, a clinic operated under the management support of SBC Medical Group, a consolidated subsidiary, presented their research findings at 'The 113th Congress of Japan Society of Aesthetic Surgery.' Yoshiyuki Aikawa, CEO of SBC Medical Group Holdings Incorporated The Japan Society of Aesthetic Surgery (JSAS), one of Japan's leading professional societies in the field of aesthetic medicine, brings together doctors dedicated to shaping the future of the industry. 'The 113th Congress of Japan Society of Aesthetic Surgery' was held over three days from Wednesday, May 28 to Friday, May 30, 2025, at The Okura Tokyo. Under the theme 'TO BE THE BEST -The Journey of Knowledge Never Ends-,' the congress was chaired in part by Dr. Ayaka Nishikawa, Director of Dermatology Department of Shonan Beauty Group, who served as Vice Chair of the event. The congress provided a valuable platform for in-depth discussions on international trends and future developments in aesthetic medicine, fostering both academic and clinical insights and promoting global collaboration among experts in the field. Dr. Ayaka Nishikawa, Director of Dermatology Department of Shonan Beauty Group, served as Vice Chair of this Congress At this congress, a total of 22 representatives from SBC Medical presented their research findings, including Yoshiyuki Aikawa, CEO of SBC Medical, Dr. Daisuke Nakamura, Chief Medical Director of Shonan Beauty Group, Dr. Kazuhiro Igawa, Representative Assistant of Shonan Beauty Group and Dr. Ayaka Nishikawa, who also served as Vice Chair of the congress. Each speaker shared insights cultivated through daily clinical practice and research in their respective fields of expertise. The event also featured lively discussions on global trends and future developments in aesthetic medicine, providing a valuable opportunity to deepen academic and clinical knowledge and to foster international collaboration. Dr. Daisuke Nakamura, Chief Medical Director of Shonan Beauty Group Dr. Kazuhiro Igawa, Representative Assistant of Shonan Beauty Group In the rapidly evolving field of aesthetic medicine, the importance of both acquiring and sharing specialized knowledge continues to grow. As technological advancements drive increasingly diverse customer needs, it is essential not only to adopt cutting-edge technologies, but also to maintain a broad and multifaceted perspective. SBC Medical remains committed to contributing to the advancement of the aesthetic medicine industry by actively engaging with academic societies and research institutions, sharing our innovative initiatives, and incorporating the latest global knowledge and technologies into our practice. The 113th Congress of Japan Society of Aesthetic Surgery Venue：The Okura Tokyo Dates：Wednesday, May 28 – Friday, May 30, 2025 Official website： Presentation Topics Chair / Speaker Job Title Title Yoshiyuki Aikawa CEO, SBC Medical Group Holdings 【Special Program/Speaker】 Practical Strategies for Cosmetic Medical Business Management and Marketing 【Special Lecture/Chair】The future of cosmetic medicine and AI Daisuke Nakamura Chief Medical Director of Shonan Beauty Group, Chief of Breast Augmentation at SBC 【Symposium/Speaker】Creating an attractive bust line - Fat injection breast augmentation and breast implant augmentation Kazuhiro Igawa Representative Assistant and Technical Advisor, Shonan Beauty Group 【Symposium/Speaker】Rhinoplasty with an awareness of harmony by considering facial parts as fonts Ayaka Nishikawa Director of Dermatology Department of Shonan Beauty Group 【Luncheon Seminar/Chair/Speaker】The Potential of Microneedle RF：Indications and Practical Combination Treatments in Skin Management 【Invited Lecture/Chair】Unique Treatments and Techniques with injectable Agents A 35 Year Evolution 【Symposium/Speaker】Challenges in Skin Tightening Devices: Insights from Single-Device Treatments with 6.78MHz Monopolar RF 【Sponsored Seminar/Chair】'The WHY'? -Why do we do what we do as an aesthetics injector? 【Presidential Special Program/Speaker】Evaluating the Impact of Different Approaches in Aesthetic Dermatology: A Post-Treatment Study in Identical Twins 【Sponsored Seminar/Speaker】Fine fiber sheet for application after pico-second laser treatment Jiro Kataoka Area Medical Director and Anti-Aging Expert Doctor 【Panel Discussion/Speaker】Deep Plane Facelift for Japanese (Asians) ~My Experience and Ideas~ 【Video Lecture/Chair】Fundamentals and applications of Facelift Surgery: Strategies for Addressing Age-Related Changes Shoko Takahashi Top expert doctor in rejuvenation 【Panel Discussion/Speaker】Patient education and combination treatment to maximize patient satisfaction with thread lifting Hiroaki Takizawa Area Doctor and Director of Jiyugaoka Clinic 【Symposium/Speaker】Revision after double eyelid surgery with sub-brow blepharoplasty Eiko Tanaka Director of Takatsuki Hospital 【Symposium/Chair/Speaker】Innovative Approaches to Improve Labia Majora Laxity: Minimizing Scars in Reduction Surgery Atsushi Hayashi Chief Technical Director 【Panel Discussion/Speaker】Incidence of Post-inflammatory Hyperpigmentation with Picosecond Laser in Patients with Melasma Kanako Misono Slimming Expert Doctor 【Luncheon Seminar/Speaker】Cutting edge of Cryolipolysis: Maximize patient satisfaction with Coolsculpting Soichiro Morikawa Anti-aging treatment expert doctor 【Luncheon Seminar/Speaker】Polynucleotide products and Hyaluronic Acid Filler Poster Presentations Speaker Job Title Title Hiroshi Ohji ー Usefulness of preoperative ultrasound examination in submandibular liposuction. Ayano Okuda Expert doctor in gynecological plastic surgery Diversifying Intimate Area Treatments ~Changes and Current Status of Pubic Hair Removal and Female Genital plastic surgery at Our Clinic~ Go Kanazawa Director of Hiroshima Clinic and Area Doctor for Hiroshima Area Lessons learned from the experience of removing limps formed by fat injection into the lower eyelid Kaito Kuzushima Ginza Clinic Director Top Expert Doctor in Liposuction Asian Buttocks Contouring：witout fat injection 【Evaluated with 3D Vectra】 Aiko Ssasaki Kawagoe Area Area Doctor and Director of Kawagoe Clinic Comparison of eyelid functions before and after completely transconjunctival embedding double eyelid blepharoplasty Yuka Takeda Director of the Esaka Institute The usefulness of next generation needle Nanosoft Microneedles Lifting Effects and Technical Innovations in Full-Face Autologous Fat Grafting Ryuji Tanaka Hokkaido/Tohoku Area General Manager Approach to the Management of Lower Eyelid Hollowness with Skin Laxity Mei Nakayama ー Bilateral symmetrical enlargement within a few months after upper arm liposuction : case report Ayaka Nishikawa Director of Dermatology Department of Shonan Beauty Group Fine fiber sheet for application after pico-second laser treatment Yu Hirata Director of Okayama Clinic and Area Doctor for Okayama Area Study on the direction of fat repositioning in transconjunctival blepharoplasty. Takashi Yamamoto Director of Nagoya Institute Examination of the effects, satisfaction, and risks of orbital fat removal combined with the buried double method Akihiro Yoshida ー Tips to improve the success rate of transconjunctival double eyelid blepharoplasty suture removal About SBC Medical SBC Medical, headquartered in Irvine, California and Tokyo, Japan, owns and provides management services and products to cosmetic treatment centers. The Company is primarily focused on providing comprehensive management services to franchisee clinics, including but not limited to advertising and marketing needs across various platforms (such as social media networks), staff management (such as recruitment and training), booking reservations for franchisee clinic customers, assistance with franchisee employee housing rentals and facility rentals, construction and design of franchisee clinics, medical equipment and medical consumables procurement (resale), the provision of cosmetic products to franchisee clinics for resale to clinic customers, licensure of the use of patent-pending and non-patented medical technologies, trademark and brand use, IT software solutions (including but not limited to remote medical consultations), management of the franchisee clinic's customer rewards program (customer loyalty point program), and payment tools for the franchisee clinics. For more information, visit Contacts In Asia: SBC Medical Group Holdings Incorporated Hikaru Fukui / Head of Investor Relations E-mail: ir@ In the US: ICR LLC Bill Zima / Managing Partner Email:
